Adam Henderson

Adam Henderson is an experienced professional who has worked in various roles across different companies in the healthcare, pharmaceutical, and technology industries. Adam currently works at Biotheranostics, Inc., where Adam serves as an Oncology Account Executive for Breast Cancer Index (BCI) and CancerTYPE ID Diagnostic Assays. Prior to this, Adam held roles at companies such as Biodesix, axogen, Pacira BioSciences, Medtronic, Ethicon, ADP, and Daiichi Sankyo, where Adam gained experience in sales, account management, and product specialization. Adam is a graduate of California State University, Chico, with a degree in Instructional Technology/Communications.